- In December 2024, Goyal Salt Limited revealed its plan to invest INR 80 crore (approximately USD 9.2 million) in setting up a new manufacturing facility in India, intended to expand its production capacity and market presence. This move supports the company’s strategy to cater to growing demand from industries such as food processing, pharmaceuticals, and industrial applications. The expansion is poised to significantly strengthen Goyal Salt’s footprint in both domestic and international markets
- In September 2024, QatarEnergy announced the formation of a joint venture to establish an industrial salt production facility valued at USD 275 million, with an annual output capacity of 1 million tons in Qatar. The plant will produce both table and industrial-grade salt to serve multiple sectors and aims to boost the country’s self-sufficiency in salt production. This strategic development is expected to reduce Qatar’s reliance on imports while supporting national industrial growth
- In March 2023, INOVYN, a U.K.-based chemical firm, introduced a sustainable, bio-based version of allyl chloride, addressing growing environmental concerns in the chemical industry. The eco-friendly variant meets the rising demand for greener chemical alternatives in various downstream applications. This launch reinforces INOVYN’s commitment to sustainability and innovation in the specialty chemicals segment
- In January 2022, the U.S. FDA approved B. Braun’s pharmaceutical manufacturing plant located in Daytona Beach, Florida, for the production of 0.9 percent sodium chloride injection solutions. The facility will produce 1,000 ml and 500 ml Excel Plus IV bags, with distribution managed from Bethlehem, Pennsylvania. This approval enhances B. Braun Medical’s supply capabilities for critical injectable solutions across healthcare facilities in the U.S
